Search

everythinglearnresearchcommunity

for

Search:↓

The document explains how hair loss in men and women, known as Androgenetic alopecia, is categorized using the Hamilton-Norwood system for men and the Ludwig grade system for women.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

The method is effective for evaluating hair loss treatments quickly and affordably.

Platelet Rich Plasma (PRP) injections can improve hair count, thickness, and strength in people with androgenic alopecia.

Researchers found 63 genes linked to male-pattern baldness, which could help in understanding its biology and developing new treatments.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Minoxidil may help treat hair loss by reducing the activity of a specific enzyme linked to baldness.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Platelet-rich plasma treatment is effective for increasing hair thickness and works well for hair density in men with androgenetic alopecia.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Severe hair loss in Chinese men is linked to high blood pressure, while in women, it's linked to larger waist size and cholesterol issues.

Sansevieria trifasciata Prain shows promise for treating hair loss by inhibiting androgen receptors.

Rosemary oil may effectively treat hair loss with fewer side effects, but more research is needed.

Compound 4 is a promising treatment for hair loss with low toxicity.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Scientists found out the structure of a human enzyme linked to prostate cancer and hair loss, which could help in designing drugs.

Botulinum toxin A may be an effective alternative treatment for the scalp disorder folliculitis decalvans.

Nanocarrier technology in cosmetics improves ingredient delivery and effectiveness while reducing side effects.

Choosing the right recall period for patient feedback is important for accurate data and depends on the disease, symptom changes, and patient impact.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

New method effectively detects illegal hormones in anti-aging foods.

Immune activities and specific genes are important in male pattern baldness.

The study found that alopecia areata and hypothyroidism increase the risk of each other, but androgenetic alopecia and hypothyroidism do not.

Men with androgenetic alopecia have different scalp oils and microbes compared to those without.

Platelet-Rich Plasma may improve skin health and reduce wrinkles, but more research is needed for standard treatment guidelines.

Most women lack knowledge about androgens and their excess symptoms.